SIC
BIIB icon

SJS Investment Consulting’s Biogen BIIB Stock Holding History

SJS Investment Consulting’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2K Buy
126
+64
+103% +$12.2K ﹤0.01% 675
2026
Q1 		$11.4K Buy
62
+50
+417% +$9.21K ﹤0.01% 805
2025
Q4 		$2.11K Buy
+12
New +$1.96K ﹤0.01% 1137
2024
Q4 		– Sell
-46
Closed -$8.92K – 1618
2024
Q3 		$8.92K Buy
46
+37
+411% +$7.74K ﹤0.01% 391
2024
Q2 		$2.09K Sell
9
-7
-44% -$1.52K ﹤0.01% 701
2024
Q1 		$3.45K Sell
16
-1
-6% -$234 ﹤0.01% 554
2023
Q4 		$4.4K Sell
17
-5
-23% -$1.23K ﹤0.01% 411
2023
Q3 		$5.66K Buy
22
+3
+16% +$802 ﹤0.01% 355
2023
Q2 		$5.41K Buy
19
+2
+12% +$595 ﹤0.01% 344
2023
Q1 		$4.73K Sell
17
-6
-26% -$1.66K ﹤0.01% 371
2022
Q4 		$6.37K Buy
23
+11
+92% +$3.11K ﹤0.01% 328
2022
Q3 		$4K Buy
+12
New +$2.55K ﹤0.01% 344
2022
Q1 		$5K Buy
23
+3
+15% +$652 ﹤0.01% 442
2021
Q4 		$5K Buy
+20
New +$5.14K ﹤0.01% 425

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SJS Investment Consulting's BIIB Position: Q2 2026 in Review

SJS Investment Consulting increased its Biogen (BIIB) stake by 103% in Q2 2026, buying an estimated $12.2K and bringing the position to 126 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #675.

SJS Investment Consulting first reported a position in BIIB in Q4 2021 and has held it in 14 quarters since. 605 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • SJS Investment Consulting held 126 shares of Biogen worth $27.2K as of Q2 2026.
  • SJS Investment Consulting bought 64 Biogen shares in Q2 2026, an estimated $12.2K.
  • Biogen made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #675 holding.
  • SJS Investment Consulting first reported a position in Biogen in Q4 2021 and has held it in 14 quarters since.
  • 605 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.